Global Medicinal Radiocompounds Market Opportunities and Forecast 2022-2028

Global Medicinal Radiocompounds Market Opportunities and Forecast 2022-2028

Report Code: KNJ1355919 | No. of Pages: | Category: Chemicals and Materials
Publisher: GRD Survey | Date of Publish: Jul-2022
This report provides a comprehensive analysis of current global Medicinal Radiocompounds market based on segmented types and downstream applications. Major product development trends are discussed  under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Medicinal Radiocompounds industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Medicinal Radiocompounds market is estimated at $  million in 2021, and projected to grow at a CAGR of % to $  million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Medicinal Radiocompounds Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Medicinal Radiocompounds market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Medicinal Radiocompounds Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Medicinal Radiocompounds industry. 
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. 
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
    Technetium 99

    Fluorine 18


Segmented by Application
    Oncology

    Cardiology

    Others


Segmented by Country
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

Key manufacturers included in this survey
    Lantheus

    Jubilant Pharma

    GE Healthcare

    Eli Lilly

    Dongcheng

    Curium Pharma

    China Isotope & Radiation

    Cardinal Health

    Bracco Imaging

    Bayer

    Acrotech Biopharma



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Medicinal Radiocompounds Market Status and Forecast (2017-2028)
        1.3.2 Global Medicinal Radiocompounds Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Medicinal Radiocompounds Supply by Company
    2.1 Global Medicinal Radiocompounds Sales Volume by Company
    2.2 Global Medicinal Radiocompounds Sales Value by Company
    2.3 Global Medicinal Radiocompounds Price by Company
    2.4 Medicinal Radiocompounds Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Medicinal Radiocompounds Market Status by Type
    3.1 Medicinal Radiocompounds Type Introduction
        3.1.1 Technetium 99

        3.1.2 Fluorine 18

        3.1.3 Other

    3.2 Global Medicinal Radiocompounds Market by Type
        3.2.1 Global Medicinal Radiocompounds Sales Volume by Type (2017-2022)
        3.2.2 Global Medicinal Radiocompounds Sales Value by Type (2017-2022)
        3.2.3 Global Medicinal Radiocompounds Price by Type (2017-2022)
    3.3 North America: by Type
    3.4 Europe: by Type
    3.5 Asia Pacific: by Type
    3.6 Central & South America: by Type
    3.7 Middle East & Africa: by Type
4 Global and Regional Medicinal Radiocompounds Market Status by Application
    4.1 Medicinal Radiocompounds Segment by Application
        4.1.1 Oncology

        4.1.2 Cardiology

        4.1.3 Others

    4.2 Global Medicinal Radiocompounds Market by Application
        4.2.1 Global Medicinal Radiocompounds Sales Volume by Application (2017-2022)
        4.2.2 Global Medicinal Radiocompounds Sales Value by Application (2017-2022)
        4.2.3 Global Medicinal Radiocompounds Price by Application (2017-2022)
    4.3 North America: by Application
    4.4 Europe: by Application
    4.5 Asia Pacific: by Application
    4.6 Central & South America: by Application
    4.7 Middle East & Africa: by Application
5 Global Medicinal Radiocompounds Market Status by Region
    5.1 Global Medicinal Radiocompounds Market by Region
        5.1.1 Global Medicinal Radiocompounds Sales Volume by Region
        5.1.2 Global Medicinal Radiocompounds Sales Value by Region
    5.2 North America Medicinal Radiocompounds Market Status
    5.3 Europe Medicinal Radiocompounds Market Status
    5.4 Asia Pacific Medicinal Radiocompounds Market Status
    5.5 Central & South America Medicinal Radiocompounds Market Status
    5.6 Middle East & Africa Medicinal Radiocompounds Market Status
6 North America Medicinal Radiocompounds Market Status
    6.1 North America Medicinal Radiocompounds Market by Country
        6.1.1 North America Medicinal Radiocompounds Sales Volume by Country (2017-2022)
        6.1.2 North America Medicinal Radiocompounds Sales Value by Country (2017-2022)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Medicinal Radiocompounds Market Status
    7.1 Europe Medicinal Radiocompounds Market by Country
        7.1.1 Europe Medicinal Radiocompounds Sales Volume by Country (2017-2022)
        7.1.2 Europe Medicinal Radiocompounds Sales Value by Country (2017-2022)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Medicinal Radiocompounds Market Status
   8.1 Asia Pacific Medicinal Radiocompounds Market by Country
        8.1.1 Asia Pacific Medicinal Radiocompounds Sales Volume by Country (2017-2022)
        8.1.2 Asia Pacific Medicinal Radiocompounds Sales Value by Country (2017-2022)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Medicinal Radiocompounds Market Status
    9.1 Central & South America Medicinal Radiocompounds Market by Country
        9.1.1 Central & South America Medicinal Radiocompounds Sales Volume by Country (2017-2022)
        9.1.2 Central & South America Medicinal Radiocompounds Sales Value by Country (2017-2022)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Medicinal Radiocompounds Market Status
    10.1 Middle East & Africa Medicinal Radiocompounds Market by Country
        10.1.1 Middle East & Africa Medicinal Radiocompounds Sales Volume by Country (2017-2022)
        10.1.2 Middle East & Africa Medicinal Radiocompounds Sales Value by Country (2017-2022)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Medicinal Radiocompounds Manufacturing Cost Analysis
    11.5 Medicinal Radiocompounds Sales Channel and Distributors Analysis
        11.5.1 Medicinal Radiocompounds Sales Channel
        11.5.2 Medicinal Radiocompounds Distributors
    11.6 Medicinal Radiocompounds Downstream Major Buyers
12 Global Medicinal Radiocompounds Market Forecast by Type and by Application
    12.1 Global Medicinal Radiocompounds Sales Volume and Sales Value Forecast (2023-2028)
    12.2 Global Medicinal Radiocompounds Forecast by Type
        12.2.1 Global Medicinal Radiocompounds Sales Volume Forecast by Type
        12.2.2 Global Medicinal Radiocompounds Sales Value Forecast by Type
        12.2.3 Global Medicinal Radiocompounds Price Forecast by Type
    12.3 Global Medicinal Radiocompounds Forecast by Application
        12.3.1 Global Medicinal Radiocompounds Sales Volume Forecast by Application
        12.3.2 Global Medicinal Radiocompounds Sales Value Forecast by Application
        12.3.3 Global Medicinal Radiocompounds Price Forecast by Application
13 Global Medicinal Radiocompounds Market Forecast by Region/Country
    13.1 Global Medicinal Radiocompounds Market Forecast by Region (2023-2028)
        13.1.1 Global Medicinal Radiocompounds Sales Volume Forecast by Region (2023-2028)
        13.1.2 Global Medicinal Radiocompounds Sales Value Forecast by Region (2023-2028)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 SIEMENS

        14.1.1 Company Information
        14.1.2 Medicinal Radiocompounds Product Introduction
        14.1.3 SIEMENS
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.1.4 SWOT Analysis
    14.2 Novartis

        14.2.1 Company Information
        14.2.2 Medicinal Radiocompounds Product Introduction
        14.2.3 Novartis
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.2.4 SWOT Analysis
    14.3 Lantheus

        14.3.1 Company Information
        14.3.2 Medicinal Radiocompounds Product Introduction
        14.3.3 Lantheus
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.3.4 SWOT Analysis
    14.4 Jubilant Pharma

        14.4.1 Company Information
        14.4.2 Medicinal Radiocompounds Product Introduction
        14.4.3 Jubilant Pharma
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.4.4 SWOT Analysis
    14.5 GE Healthcare

        14.5.1 Company Information
        14.5.2 Medicinal Radiocompounds Product Introduction
        14.5.3 GE Healthcare
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.5.4 SWOT Analysis
    14.6 Eli Lilly

        14.6.1 Company Information
        14.6.2 Medicinal Radiocompounds Product Introduction
        14.6.3 Eli Lilly
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.6.4 SWOT Analysis
    14.7 Dongcheng

        14.7.1 Company Information
        14.7.2 Medicinal Radiocompounds Product Introduction
        14.7.3 Dongcheng
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.7.4 SWOT Analysis
    14.8 Curium Pharma

        14.8.1 Company Information
        14.8.2 Medicinal Radiocompounds Product Introduction
        14.8.3 Curium Pharma
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.8.4 SWOT Analysis
    14.9 China Isotope & Radiation

        14.9.1 Company Information
        14.9.2 Medicinal Radiocompounds Product Introduction
        14.9.3 China Isotope & Radiation
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.9.4 SWOT Analysis
    14.10 Cardinal Health

        14.10.1 Company Information
        14.10.2 Medicinal Radiocompounds Product Introduction
        14.10.3 Cardinal Health
 Medicinal Radiocompounds Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.10.4 SWOT Analysis
    14.11 Bracco Imaging

    14.12 Bayer

    14.13 Acrotech Biopharma

15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com